Antitrust Enforcement
California Legislature’s Healthcare Reform Efforts Have Mixed Results
Leelah Klauber October 12, 2026
Now that California’s legislative session has ended, the final tallies are being compiled on what bills were signed into law and which were vetoed. Governor Newsom acted on 1,160 bills during the 2026 legislative session on topics from data centers to limiting social media for teenagers. The Source wants to highlight two influential bills with implications for health care in California: SB 1037, which would have changed how health insurance rates are reviewed, and AB 1776, which expands the state’s antitrust law. SB 1037 SB 1037 is under consideration by […]
Continue Reading
Davis v. HCA Case Likely to Continue Despite Ruling Denying Class Certification
Bruce Allain, Managing Editor October 4, 2026
On September 8, 2026, Special Superior Court Judge Mark A. Davis ruled against class certification for plaintiffs in the Davis et al. v. HCA Healthcare and Mission Health System antitrust case. The decision rested primarily on the judge’s belief that plaintiffs had not proved proposed class members paid higher premiums as a result of defendants abusing monopoly market power. History of the Case On February 1, 2019, HCA Healthcare completed a $1.5 billion acquisition of Mission Health, a non-profit system located in western North Carolina. The deal gave HCA 185 […]
Continue Reading
New Podcast: Cross-Market Mergers and the Next Frontier in Healthcare Antitrust
Megan Bochum August 6, 2026
The Source’s Katie Gudiksen joined Jaime King and host Andréa Caballero of Catalyst for Payment Reform on the latest episode of Listening In (With Permission) to discuss cross-market hospital mergers and the challenges they pose for antitrust enforcement. In the conversation, Gudiksen and King explain why mergers between hospitals in separate geographic areas have become the leading form of hospital consolidation, and why these deals can raise prices even though the combining systems do not compete for the same patients. The higher prices come from two reinforcing sources: the market […]
Continue Reading
DOJ and State of Ohio Announce a Settlement of Anticompetitive Contracting Case
Bruce Allain, Managing Editor June 27, 2026
On February 20, 2026, the Department of Justice (DOJ) and the Ohio Attorney General’s office filed suit against OhioHealth, a 16-hospital nonprofit health system, claiming that OhioHealth’s use of all-or-nothing terms (requiring insurers to include all of its providers in their networks) inflates costs for policyholders and disadvantages competitors. The suit also claimed that OhioHealth’s contracts included terms requiring OhioHealth to be at the most-favored level of benefits in each network, and that payors were prevented from providing patients with price information about healthcare services. The Source published an analysis of this case in March. […]
Continue Reading
Tennessee Sued Over Structural Approach to PBM Vertical Integration
Bruce Allain, Managing Editor June 12, 2026
Across the healthcare system, companies that once occupied a single layer of the supply chain increasingly own the layers above and below them, and that vertical consolidation can raise costs, narrow patient choice, and create conflicts of interest when one firm both sets prices and competes in the market it is pricing. Pharmacy benefit managers (PBMs) are a prime example of the potential for harms created by vertical consolidation. A PBM sits between health plans and pharmacies and determines how much the pharmacy is reimbursed when it dispenses a drug, […]
Continue Reading
Ninth Circuit Wields the First Amendment to Strike Down California Dialysis Law
Source Fellow May 15, 2026
On Tuesday, April 7, 2026, the 9th U.S. Circuit Court of Appeals struck down key provisions of California’s Assembly Bill 290 (2019), a law that capped the reimbursement rates dialysis providers could collect from private insurers for patients receiving premium assistance from charitable organizations and required related patient disclosures. The court held that the reimbursement cap and disclosure provisions violated the First Amendment by burdening the American Kidney Fund’s right to associate with dialysis providers DaVita and Fresenius, and that California had not narrowly tailored the law to its asserted […]
Continue Reading
California Enacts the Uniform Antitrust Premerger Notification Act
Kassie Williams April 29, 2026
On February 10, 2026, California Governor Gavin Newsom signed SB 25 into effect, enacting the California Uniform Antitrust Premerger Notification Act. Introduced by Senator Tom Umberg, the new law mandates that companies required to file federal premerger notifications under the federal Hart-Scott-Rodino (HSR) Act also file the information with the California Attorney General. California is following Washington and Colorado in enacting a version of the Uniform Antitrust Premerger Notification Act, model legislation proposed by the Uniform Law Commission. Although the new law gives no new enforcement powers, it expands the […]
Continue Reading
Sutter Health Attempting to Complete Cross-Market Merger with Allina Health
Bruce Allain, Managing Editor April 8, 2026
In mid-March 2026, Sutter Health and Allina Health announced the signing of a Letter of Intent to merge the healthcare systems. Sacramento-based Sutter Health has more than 600 locations and 27 hospitals, and reported $19.8 billion in total revenue and $509 million in operating income in 2025. Sutter Health has come under fire in recent years with claims that it has improperly used its market power to impose anticompetitive contract terms, restricting competition and driving up the cost of care. Minneapolis-based Allina Health has 12 hospitals and 100 additional care […]
Continue Reading
The Source Roundup: April 2026 Edition
Leelah Klauber April 1, 2026
Antitrust and Market Competition Playing Favorites — State Protection of Academic Medical Centers from Antitrust Oversight New England Journal of Medicine Jaime S. King, Katherine L. Gudiksen, Anna D. Sinaiko The authors explore a new trend with U.S. academic medical centers (AMCs) merging with nonacademic hospitals and health care systems. These mergers pose risks of price increases and other competitive harms. Regulators should review all transactions involving an AMC and ensure that any promised benefits from consolidation do not harm the public. Notably, at least four states have laws explicitly […]
Continue Reading
The Source Staff Co-Author New Research on the State Protection of Academic Medical Centers from Antitrust Oversight
Bruce Allain, Managing Editor March 25, 2026
The Source’s founder Jaime S. King, and executive editor Katherine L. Gudiksen, working with Harvard’s Anna D. Sinaiko, have authored a report on state antitrust exemptions for academic medical centers (AMCs) published recently by the New England Journal of Medicine. There is a recent history of AMCs merging with nonacademic systems, with states creating “carve-outs” to exempt AMCs from antitrust oversight. The research indicates that such exemptions are unwise and that states should engage in reviews of AMC transactions to ensure they actually deliver public benefits while minimizing consumer harm. Read the full paper here: https://www.nejm.org/doi/full/10.1056/NEJMp2514565
Continue Reading